Akebia Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.

About AKBA

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. 

CEO
John P. Butler
CEOJohn P. Butler
Employees
194
Employees194
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2007
Founded2007
Employees
194
Employees194

AKBA Key Statistics

Market cap
347.34M
Market cap347.34M
Price-Earnings ratio
-16.71
Price-Earnings ratio-16.71
Dividend yield
Dividend yield
Average volume
2.31M
Average volume2.31M
High today
$0.9933
High today$0.9933
Low today
$0.9833
Low today$0.9833
Open price
$1.32
Open price$1.32
Volume
283.73K
Volume283.73K
52 Week high
$3.79
52 Week high$3.79
52 Week low
$0.8227
52 Week low$0.8227

Stock Snapshot

Akebia Therapeutics(AKBA) stock is priced at $0.99, giving the company a market capitalization of 347.34M. It carries a P/E multiple of -16.71.

On 2026-08-06, Akebia Therapeutics(AKBA) stock traded between a low of $0.98 and a high of $0.99. Shares are currently priced at $0.99, which is +1.0% above the low and 0.0% below the high.

The Akebia Therapeutics(AKBA)'s current trading volume is 283.73K, compared to an average daily volume of 2.31M.

In the last year, Akebia Therapeutics(AKBA) shares hit a 52-week high of $3.79 and a 52-week low of $0.82.

In the last year, Akebia Therapeutics(AKBA) shares hit a 52-week high of $3.79 and a 52-week low of $0.82.

AKBA News

Investing.com 11h
Earnings call transcript: Akebia Therapeutics posts mixed Q2 2026 results as stock falls - Investing.com

...

Earnings call transcript: Akebia Therapeutics posts mixed Q2 2026 results as stock falls - Investing.com

People also own

Based on the portfolios of people who own AKBA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.